Skip to main content
OpenTrials

Clinical trial condition

Hyperlipoproteinemias

Explore clinical trials studying Hyperlipoproteinemias. Study availability and eligibility vary by location and protocol.

231 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipoproteinemias trial results

Completed

Type III Dysbetalipoproteinemia

NCT00214604

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +8 more
Locations
  • Research Site Oslo, Norway
  • Research Site Cape Town, South Africa
View Trial Details
Completed

A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides

NCT00134498

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Pfizer Investigational Site Anaheim, California, United States
  • Pfizer Investigational Site Huntington Beach, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Orange, California, United States
View all 44 locations
View Trial Details
Completed

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder

NCT00134511

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Pfizer Investigational Site Boston, Massachusetts, United States
  • Pfizer Investigational Site Chicoutimi, Quebec, Canada
  • Pfizer Investigational Site Ste-Foy, Quebec, Canada
  • Pfizer Investigational Site Parktown, Johannesburg, South Africa
View Trial Details
Completed

Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia

NCT00134485

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site Washington D.C., District of Columbia, United States
  • Pfizer Investigational Site Lutz, Florida, United States
  • Pfizer Investigational Site Tampa, Florida, United States
View all 41 locations
View Trial Details

Related conditions